|
|
||||||||
Department of Surgery, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, Amsterdam, 1066 CX Netherlands
(Email: h.klomp@nki.nl).
| The first 20% of the full text of this article appears below. |
To the Editor:
With some concern we read the article by Mansour and colleagues [1] in the July 2008 issue of The Annals of Thoracic Surgery on the outcome in patients with nonsmall cell lung cancer (NSCLC) and N2 disease after pneumonectomy. They discuss the question of whether it is reasonable to subject a patient to this high-risk procedure
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |